Recent Updates
Recently added Catalysts
INDV Neutral Sentiment

INDIVIOR PLC (THE 'COMPANY') - DIRECTOR/PDMR SHAREHOLDINGS - CORRECTION The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on

Key Takeaway: Indivior PLC announced a correction to its previous 'Director/PDMR Shareholding' statement. An error in the number of shares acquired by Non-Executive Director Mark Stejbach was corrected from 1,400 to 1,300 shares. Following this purchase, Stejbach now holds 9,584 shares in total. The transaction took place on March 6, 2023, at an average price of £15.0229 per share, and details regarding other shareholdings remained unchanged.
Price reaction · baseline $17.77 (2024-01-24 close) · hit after-hours · 1 other INDV headline(s) in the window, move may be shared
day 0 close
+0.5%

Market Sentiment Analysis

CONCERNS & RISKS

  • The initial share acquisition was incorrectly reported, indicating potential administrative oversight.
  • The need for correction may suggest issues with the company's communication or reporting processes.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
5.4%
average across 2 past catalysts
Lead asset
RBP-6000
Phase 3 · Opioid Use Disorder

Full Press Release Details

INDIVIOR PLC (THE 'COMPANY') - DIRECTOR/PDMR SHAREHOLDINGS -
amendment has been made to the 'Director/PDMR Shareholding'
announcement released on March 8, 2023
In relation to the shares acquired by Mark Stejbach on March 6,
2023, the number of shares purchased was incorrectly stated due to
administrative error and has been corrected from 1,400 to
As at the date of this announcement, Mark Stejbach has an interest
in 12,584 shares in the Company.
All other details remain unchanged.
The full amended text is shown below.
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS
CLOSELY ASSOCIATED WITH THEM
The Company announces that it received notification on March 7,
2023 that Mark Stejbach, a
Non-Executive Director of the Company, acquired 1,300 shares
at an average price of 15.0229 per share on March 6,
Following this transaction, Mark Stejbach has an interest in 9,584
shares in the Company.
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Mark Stejbach
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Amendment
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Indivior PLC
b) LEI 213800V3NCQTY7IED471
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary Shares of US$0.50 ISIN: GB00BN4HT335
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
GBP 15.0229 1,300
d) Aggregated information - Aggregated volume - Price N/A
e) Date of the transaction March 6, 2023
f) Place of the transaction London Stock Exchange (XLON)

Frequently Asked Questions

What was the error in the shareholding announcement?

The shareholding announcement incorrectly stated 1,400 shares instead of 1,300.

Who is Mark Stejbach?

Mark Stejbach is a Non-Executive Director of Indivior PLC.

How many shares does Mark Stejbach currently hold?

Mark Stejbach currently holds an interest in 12,584 shares.

When did Mark Stejbach acquire the shares?

Mark Stejbach acquired the shares on March 6, 2023.

What is the average price of the shares acquired?

The average price of the shares acquired was GBP 15.0229 each.

Last updated: Jan 25, 2024